Methylene Blue
A compound explored at low doses for mitochondrial and cognitive support.
Not available yet · be first to know when it launches
Methylene Blue
Methylene blue is a compound explored at low doses for mitochondrial function and cognitive support. Human evidence for many of its proposed benefits is still early, and we consider it only for eligible patients under clinical oversight.
What it may help support
- Cellular energy (explored)
- Cognitive support (explored)
Delivery
A low-dose oral preparation, considered and guided by a clinician for eligible patients.
An honest word on the evidence
Interest runs ahead of the long-term human evidence. We keep it clinician-led with realistic expectations and quality sourcing. Results vary.
How it works here
Every plan follows one path. Each step feeds the next. See the NAD+ Therapy approach.
- 01
Measure
We baseline your labs, history, and goals.
- 02
Plan
A clinician decides whether this fits — and what else might serve you.
- 03
Act
If appropriate, you start with clear guidance and high-touch support.
- 04
Track
We monitor how you respond on a defined cadence.
- 05
Adjust
Protocols are refined over time. Guided care, not a kit in the mail.
Frequently asked questions
No. Any use for energy or cognition is off-label; we consider it only under clinical oversight.
Safety depends on dose, source, and monitoring. It isn't right for everyone and requires clinical evaluation.
Often considered alongside
Methylene Blue is on the way
We're finalizing this treatment now. Join the waitlist and we'll email you the moment it's available — no spam, just the launch.
We measure first. Then we act.
ACT 2 Health provides clinician-led care. Treatments described are available only to eligible patients following clinical evaluation and within applicable regulations. This page is educational and is not medical advice. Individual results vary.